These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32582365)

  • 1. Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer.
    De Re V; Caggiari L; De Zorzi M; Fanotto V; Miolo G; Puglisi F; Cannizzaro R; Canzonieri V; Steffan A; Farruggia P; Lopci E; d'Amore ESG; Burnelli R; Mussolin L; Mascarin M
    Infect Agent Cancer; 2020; 15():42. PubMed ID: 32582365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting E2F3.
    Park MC; Kim H; Choi H; Chang MS; Lee SK
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus miR-BART17-5p Promotes Migration and Anchorage-Independent Growth by Targeting Kruppel-Like Factor 2 in Gastric Cancer.
    Yoon JH; Min K; Lee SK
    Microorganisms; 2020 Feb; 8(2):. PubMed ID: 32075248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.
    Zhou L; Bu Y; Liang Y; Zhang F; Zhang H; Li S
    Med Sci Monit; 2016 Oct; 22():4114-4120. PubMed ID: 27796281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved sequences of BART and BHRF regions encoding viral microRNAs in Epstein-Barr virus-associated lymphoma.
    Sunagawa K; Hishima T; Fukumoto H; Hasegawa H; Katano H
    BMC Res Notes; 2017 Jul; 10(1):279. PubMed ID: 28705173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-encoded miR-BART11-3p modulates the DUSP6-MAPK axis to promote gastric cancer cell proliferation and metastasis.
    Xu M; Lin J; Yang S; Yao J; Chen M; Feng J; Zhang L; Zhou L; Zhang J; Qin Q
    J Virol; 2023 Sep; 97(9):e0088123. PubMed ID: 37681959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Changes in Gastric Carcinogenesis: Differential Dysregulation during
    Prinz C; Mese K; Weber D
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival.
    Kang D; Skalsky RL; Cullen BR
    PLoS Pathog; 2015 Jun; 11(6):e1004979. PubMed ID: 26070070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Viral microRNAs in the Oncogenesis of Epstein-Barr Virus-Associated Lymphoma.
    Kimura H; Okuno Y; Sato Y; Watanabe T; Murata T
    Front Microbiol; 2021; 12():667968. PubMed ID: 34305835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma.
    Higuchi H; Yamakawa N; Imadome KI; Yahata T; Kotaki R; Ogata J; Kakizaki M; Fujita K; Lu J; Yokoyama K; Okuyama K; Sato A; Takamatsu M; Kurosaki N; Alba SM; Azhim A; Horie R; Watanabe T; Kitamura T; Ando K; Kashiwagi T; Matsui T; Okamoto A; Handa H; Kuroda M; Nakamura N; Kotani A
    Blood; 2018 Jun; 131(23):2552-2567. PubMed ID: 29685921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders.
    van Beek J; Brink AATP; Vervoort MBHJ; van Zijp MJM; Meijer CJLM; van den Brule AJC; Middeldorp JM
    J Gen Virol; 2003 Oct; 84(Pt 10):2647-2659. PubMed ID: 13679598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor.
    Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H
    J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy.
    Lung RW; Tong JH; To KF
    Int J Mol Sci; 2013 Aug; 14(9):17378-409. PubMed ID: 23979421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From virus to cancer: Epstein-Barr virus miRNA connection in Burkitt's lymphoma.
    Jalilian S; Bastani MN
    Infect Agent Cancer; 2024 Oct; 19(1):54. PubMed ID: 39425210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
    Iizasa H; Kim H; Kartika AV; Kanehiro Y; Yoshiyama H
    Front Immunol; 2020; 11():367. PubMed ID: 32194570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of MicroRNA Cluster miR-183-96-182 Expression by Epstein-Barr Virus Latent Membrane Protein 1.
    Oussaief L; Fendri A; Chane-Woon-Ming B; Poirey R; Delecluse HJ; Joab I; Pfeffer S
    J Virol; 2015 Dec; 89(23):12178-88. PubMed ID: 26401047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.